LANXESS IS NO GERMAN ARKEMA QUITE YET (REDUCE; +8% UPSIDE)
01/10/24 -" Lanxess’ (Reduce; Germany) equity story is a difficult one. At first sight, the company seems to have the portfolio rotation gene, but there is hardly any positive effect to be identified. Lanxess ..."
Pages
62
Language
English
Published on
01/10/24
You may also be interested by these reports :
06/11/25
Lanxess’s weak Q3 2025 results weighed heavily on investor sentiment, with shares down 12% as of writing. The company faced subdued end-market demand ...
06/11/25
The company faces challenges due to weak demand in its end markets. Management has made initial progress in restructuring, but improvement in these ...
03/11/25
Fuchs’ Q3 2025 results, although muted, came in line with street expectations. Sales were supported by strong performance in Asia and the Americas. ...
03/11/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...